Compass Advisory Group LLC acquired a new stake in shares of Tilray Inc (NASDAQ:TLRY - Get Rating) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 105,667 shares of the company's stock, valued at approximately $342,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in TLRY. Mercer Global Advisors Inc. ADV raised its holdings in shares of Tilray by 10.0% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 28,072 shares of the company's stock valued at $77,000 after purchasing an additional 2,550 shares in the last quarter. Rhumbline Advisers raised its holdings in shares of Tilray by 20.4% in the 2nd quarter. Rhumbline Advisers now owns 15,464 shares of the company's stock valued at $48,000 after purchasing an additional 2,623 shares in the last quarter. Resources Investment Advisors LLC. raised its holdings in shares of Tilray by 25.1% in the 3rd quarter. Resources Investment Advisors LLC. now owns 14,429 shares of the company's stock valued at $40,000 after purchasing an additional 2,895 shares in the last quarter. CreativeOne Wealth LLC raised its holdings in shares of Tilray by 8.0% in the 3rd quarter. CreativeOne Wealth LLC now owns 40,591 shares of the company's stock valued at $112,000 after purchasing an additional 2,994 shares in the last quarter. Finally, Rockefeller Capital Management L.P. raised its holdings in shares of Tilray by 17.9% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 20,834 shares of the company's stock valued at $57,000 after purchasing an additional 3,162 shares in the last quarter. Institutional investors own 11.59% of the company's stock.
Analyst Ratings Changes
Several equities research analysts have recently commented on TLRY shares. Atb Cap Markets restated a "sector perform" rating on shares of Tilray in a report on Thursday, February 9th. Alliance Global Partners reduced their price target on shares of Tilray from $4.00 to $3.00 and set a "neutral" rating for the company in a report on Monday, January 9th. Two research analysts have rated the stock with a sell rating and six have assigned a hold rating to the company. According to data from MarketBeat, Tilray has a consensus rating of "Hold" and a consensus target price of $4.72.
Tilray Stock Performance
NASDAQ TLRY opened at $2.62 on Friday. Tilray Inc has a 52 week low of $2.28 and a 52 week high of $9.08. The company has a current ratio of 1.91, a quick ratio of 1.35 and a debt-to-equity ratio of 0.09. The company has a 50 day moving average price of $2.87 and a 200 day moving average price of $3.19.
Tilray (NASDAQ:TLRY - Get Rating) last released its earnings results on Monday, January 9th. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.01). The company had revenue of $144.10 million for the quarter, compared to analysts' expectations of $157.21 million. Tilray had a negative return on equity of 5.10% and a negative net margin of 89.96%. Tilray's revenue was down 7.1% on a year-over-year basis. Equities research analysts predict that Tilray Inc will post -0.33 earnings per share for the current fiscal year.
Tilray Company Profile
(
Get Rating)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.
Get This Free Report
